Colorado-based Vantage Hemp Co. is expanding into the Australian CBD market via a partnership with Medcan Australia.
Under the agreement, Vantage will supply Medcan with a range of high-quality crude oil, full-spectrum oil, distillate, isolate and CBS Active Pharmaceutical Ingredient (API) products for medical use.
Vantage director of sales and marketing Christian Santi said: “We’re pleased to join the Australian medical cannabis community. The opportunity will allow Vantage to… help meet the increased patient demand for CBD products.”
Vantage will provide GMP-compliant premium extracts which it says will “set the stage for a new level of standards and innovative products in Australia’s CBD market”.
Santi added: “This strategic partnership further validates the quality of our products and the strength of our science-driven, data-backed value proposition. It’s another important step forward to position Vantage as a leader in CBD extraction and becoming a globally recognised brand by increasing our foothold in international markets.
“We’re looking forward to collaborating with Medcan to bring trusted, quality products to patients.”
Medcan Australia founder and CEO Craig Cochran added: “Now more than ever, it’s important to meet the growing interest from patients with quality products that will provide effective results.”
“Partnering with Vantage Hemp gives us the ability to extend the scope of our products to offer greater support and variety to patients across Australia.”